Cargando…

Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis

BACKGROUND: Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides difficile infection (CDI), but inconsistent effect rates and uncertain evidence levels have warranted caution. To clarify, we aimed to establish the evidence of FMT for recurrent CDI, updated across differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baunwall, Simon Mark Dahl, Lee, Mads Ming, Eriksen, Marcel Kjærsgaard, Mullish, Benjamin H., Marchesi, Julian R., Dahlerup, Jens Frederik, Hvas, Christian Lodberg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788438/ https://www.ncbi.nlm.nih.gov/pubmed/33437951 http://dx.doi.org/10.1016/j.eclinm.2020.100642

Ejemplares similares

Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
por: Wei, Shaodong, et al.
Publicado: (2022)

Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review
por: Hammeken, Lianna Hede, et al.
Publicado: (2021)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Hypophosphatemia in a Specialized Intestinal Failure Unit: An Observational Cohort Study
por: Eriksen, Marcel Kjærsgaard, et al.
Publicado: (2020)

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
por: Cold, Frederik, et al.
Publicado: (2021)

Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity
por: Hvas, Christian Lodberg, et al.
Publicado: (2020)

Health-related quality of life in patients with recurrent Clostridioides difficile infections
por: Hammeken, Lianna H., et al.
Publicado: (2022)

Faecal microbiota transplantation as a home therapy to frail older people
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2020)

Systematic review with meta‐analysis: effects of implementing a nutrition support team for in‐hospital parenteral nutrition
por: Eriksen, Marcel Kjærsgaard, et al.
Publicado: (2021)

Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
por: Grosen, Anne Karmisholt, et al.
Publicado: (2019)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity
por: Rubak, Tone, et al.
Publicado: (2023)

Meeting update: faecal microbiota transplantation––bench, bedside, courtroom?
por: Ding, Nik Sheng, et al.
Publicado: (2018)

Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020)

Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
por: Jeon, Yong Duk, et al.
Publicado: (2019)

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
por: D. Goldenberg, Simon, et al.
Publicado: (2021)

Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances
por: Wei, Shaodong, et al.
Publicado: (2021)

The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Clostridioides difficile Infection in Italy
por: de Stefano, Maria Chiara, et al.
Publicado: (2022)

Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report
por: Wei, Shaodong, et al.
Publicado: (2022)

Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection
por: Abdali, Zainab I, et al.
Publicado: (2020)

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study
por: Svensson, Camilla Kara, et al.
Publicado: (2022)

The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2021)

Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms
por: Baek, Olivia Dybro, et al.
Publicado: (2023)

Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway
por: Monaghan, Tanya, et al.
Publicado: (2018)

Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank
por: Terveer, Elisabeth M, et al.
Publicado: (2020)

Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease
por: Segal, Jonathan P., et al.
Publicado: (2020)

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
por: van Lingen, Emilie (E.), et al.
Publicado: (2023)

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
por: Brown, Jillian R.-M., et al.
Publicado: (2018)

The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
por: Mullish, Benjamin H., et al.
Publicado: (2021)

Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital
por: Barberio, Brigida, et al.
Publicado: (2020)

Faecal microbiota transplantation as a non-standard therapy for the treatment of Clostridioides difficile in an ulcerative colitis patient
por: Pendrasik, Karolina, et al.
Publicado: (2022)

Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel
por: Ianiro, Gianluca, et al.
Publicado: (2022)

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites
por: Martinez-Gili, Laura, et al.
Publicado: (2020)

Recruitment of feces donors among blood donors: Results from an observational cohort study
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2018)

B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiamine
por: Bager, Palle, et al.
Publicado: (2023)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Faecal carriage of Clostridioides difficile is low among veterinary healthcare workers in the Netherlands
por: Meijs, Anouk P., et al.
Publicado: (2022)

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)

Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature
por: Hvas, Christian Lodberg, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4p6jpjm2n4l340hsonjn4t26ea